Methionine aminopeptidase-2 blockade reduces chronic collagen-induced arthritis: potential role for angiogenesis inhibition
Open Access
- 11 December 2007
- journal article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 9 (6) , R127
Abstract
The enzyme methionine aminopeptidase-2 (MetAP-2) is thought to play an important function in human endothelial cell proliferation, and as such provides a valuable target in both inflammation and cancer. Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with increased synovial vascularity, and hence is a potential therapeutic target for angiogenesis inhibitors. We examined the use of PPI-2458, a selective non-reversible inhibitor of MetAP-2, in disease models of RA, namely acute and chronic collagen-induced arthritis (CIA) in mice. Whilst acute CIA is a monophasic disease, CIA induced with murine collagen type II manifests as a chronic relapsing arthritis and mimics more closely the disease course of RA. Our study showed PPI-2458 was able to reduce clinical signs of arthritis in both acute and chronic CIA models. This reduction in arthritis was paralleled by decreased joint inflammation and destruction. Detailed mechanism of action studies demonstrated that PPI-2458 inhibited human endothelial cell proliferation and angiogenesis in vitro, without affecting production of inflammatory cytokines. Furthermore, we also investigated release of inflammatory cytokines and chemokines from human RA synovial cell cultures, and observed no effect of PPI-2458 on spontaneous expression of cytokines and chemokines, or indeed on the angiogenic molecule vascular endothelial growth factor (VEGF). These results highlight MetAP-2 as a good candidate for therapeutic intervention in RA.Keywords
This publication has 50 references indexed in Scilit:
- Angiogenesis as a Therapeutic Target in Arthritis: Lessons from OncologyCurrent Pharmaceutical Design, 2006
- VEGF is a modifier of amyotrophic lateral sclerosis in mice and humans and protects motoneurons against ischemic deathNature Genetics, 2003
- Raised serum vascular endothelial growth factor levels are associated with destructive change in inflammatory arthritisArthritis & Rheumatism, 2001
- Structure and function of the methionine aminopeptidasesBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology, 2000
- Modulation of angiogenic vascular endothelial growth factor by tumor necrosis factor ? and interleukin-1 in rheumatoid arthritisArthritis & Rheumatism, 1998
- Focally regulated endothelial proliferation and cell death in human synovium.1998
- Blood Vessel Formation: What Is Its Molecular Basis?Cell, 1996
- Angiogenesis in cancer, vascular, rheumatoid and other diseaseNature Medicine, 1995
- Vascular endothelial growth factor. A cytokine modulating endothelial function in rheumatoid arthritis.The Journal of Immunology, 1994
- Analysis of the histologic variation of synovitis in rheumatoid arthritisArthritis & Rheumatism, 1988